Cargando…

The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer

OBJECTIVE: To evaluate the utility of apparent diffusion coefficient (ADC) values for differentiating breast tumors. METHODS: The medical records of 17 patients with phyllodes tumor [PT; circular regions of interest (ROI-cs) n = 171], 74 patients with fibroadenomas (FAs; ROI-cs, n = 94), and 57 pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Jinzhi, Zhang, Yuzhong, Li, Ruifeng, Liang, Lanlan, Yu, Juan, Hu, Ziqi, Zhou, Lingling, Liu, Renwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018141/
https://www.ncbi.nlm.nih.gov/pubmed/36937381
http://dx.doi.org/10.3389/fonc.2023.938189
_version_ 1784907748144578560
author Fang, Jinzhi
Zhang, Yuzhong
Li, Ruifeng
Liang, Lanlan
Yu, Juan
Hu, Ziqi
Zhou, Lingling
Liu, Renwei
author_facet Fang, Jinzhi
Zhang, Yuzhong
Li, Ruifeng
Liang, Lanlan
Yu, Juan
Hu, Ziqi
Zhou, Lingling
Liu, Renwei
author_sort Fang, Jinzhi
collection PubMed
description OBJECTIVE: To evaluate the utility of apparent diffusion coefficient (ADC) values for differentiating breast tumors. METHODS: The medical records of 17 patients with phyllodes tumor [PT; circular regions of interest (ROI-cs) n = 171], 74 patients with fibroadenomas (FAs; ROI-cs, n = 94), and 57 patients with breast cancers (BCs; ROI-cs, n = 104) confirmed by surgical pathology were retrospectively reviewed. RESULTS: There were significant differences between PTs, FAs, and BCs in ADCmean, ADCmax, and ADCmin values. The cutoff ADCmean for differentiating PTs from FAs was 1.435 × 10(−3) mm(2)/s, PTs from BCs was 1.100 × 10(−3) mm(2)/s, and FAs from BCs was 0.925 × 10(−3) mm(2)/s. There were significant differences between benign PTs, borderline PTs, and malignant PTs in ADCmean, ADCmax, and ADCmin values. The cutoff ADCmean for differentiating benign PTs from borderline PTs was 1.215 × 10(−3) mm(2)/s, and borderline PTs from malignant PTs was 1.665 × 10(−3) mm(2)/s. CONCLUSION: DWI provides quantitative information that can help distinguish breast tumors.
format Online
Article
Text
id pubmed-10018141
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100181412023-03-17 The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer Fang, Jinzhi Zhang, Yuzhong Li, Ruifeng Liang, Lanlan Yu, Juan Hu, Ziqi Zhou, Lingling Liu, Renwei Front Oncol Oncology OBJECTIVE: To evaluate the utility of apparent diffusion coefficient (ADC) values for differentiating breast tumors. METHODS: The medical records of 17 patients with phyllodes tumor [PT; circular regions of interest (ROI-cs) n = 171], 74 patients with fibroadenomas (FAs; ROI-cs, n = 94), and 57 patients with breast cancers (BCs; ROI-cs, n = 104) confirmed by surgical pathology were retrospectively reviewed. RESULTS: There were significant differences between PTs, FAs, and BCs in ADCmean, ADCmax, and ADCmin values. The cutoff ADCmean for differentiating PTs from FAs was 1.435 × 10(−3) mm(2)/s, PTs from BCs was 1.100 × 10(−3) mm(2)/s, and FAs from BCs was 0.925 × 10(−3) mm(2)/s. There were significant differences between benign PTs, borderline PTs, and malignant PTs in ADCmean, ADCmax, and ADCmin values. The cutoff ADCmean for differentiating benign PTs from borderline PTs was 1.215 × 10(−3) mm(2)/s, and borderline PTs from malignant PTs was 1.665 × 10(−3) mm(2)/s. CONCLUSION: DWI provides quantitative information that can help distinguish breast tumors. Frontiers Media S.A. 2023-03-02 /pmc/articles/PMC10018141/ /pubmed/36937381 http://dx.doi.org/10.3389/fonc.2023.938189 Text en Copyright © 2023 Fang, Zhang, Li, Liang, Yu, Hu, Zhou and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Fang, Jinzhi
Zhang, Yuzhong
Li, Ruifeng
Liang, Lanlan
Yu, Juan
Hu, Ziqi
Zhou, Lingling
Liu, Renwei
The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer
title The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer
title_full The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer
title_fullStr The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer
title_full_unstemmed The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer
title_short The utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer
title_sort utility of diffusion-weighted imaging for differentiation of phyllodes tumor from fibroadenoma and breast cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018141/
https://www.ncbi.nlm.nih.gov/pubmed/36937381
http://dx.doi.org/10.3389/fonc.2023.938189
work_keys_str_mv AT fangjinzhi theutilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT zhangyuzhong theutilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT liruifeng theutilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT lianglanlan theutilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT yujuan theutilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT huziqi theutilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT zhoulingling theutilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT liurenwei theutilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT fangjinzhi utilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT zhangyuzhong utilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT liruifeng utilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT lianglanlan utilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT yujuan utilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT huziqi utilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT zhoulingling utilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer
AT liurenwei utilityofdiffusionweightedimagingfordifferentiationofphyllodestumorfromfibroadenomaandbreastcancer